Cathepsin K (CTSK), a proteolytic enzyme that degradesthe extracellularmatrix, is recognized as a significant therapeutic target for osteoporosis,osteoarthritis, and rheumatoid arthritis. This evidence concerns the gene CTSK and rheumatoid arthritis.